These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32104083)

  • 1. Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.
    Xu F; Wang D; Cui J; Li J; Jiang H
    Cancer Manag Res; 2020; 12():1017-1027. PubMed ID: 32104083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.
    Liu J; Xu F; Li J; Jiang H
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32452513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
    Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
    J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD3/CD28 dynabeads induce expression of tn antigen in human t cells accompanied by hypermethylation of the cosmc promoter.
    Shi C; Xu X; Yu X; Du Z; Luan X; Liu D; Hu T
    Mol Immunol; 2017 Oct; 90():98-105. PubMed ID: 28708980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens [Retraction].
    Cancer Manag Res; 2022; 14():3119-3120. PubMed ID: 36353503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
    Ju T; Lanneau GS; Gautam T; Wang Y; Xia B; Stowell SR; Willard MT; Wang W; Xia JY; Zuna RE; Laszik Z; Benbrook DM; Hanigan MH; Cummings RD
    Cancer Res; 2008 Mar; 68(6):1636-46. PubMed ID: 18339842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    Sun X; Ju T; Cummings RD
    BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
    Beatson R; Maurstad G; Picco G; Arulappu A; Coleman J; Wandell HH; Clausen H; Mandel U; Taylor-Papadimitriou J; Sletmoen M; Burchell JM
    PLoS One; 2015; 10(5):e0125994. PubMed ID: 25951175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.
    Yu X; Du Z; Sun X; Shi C; Zhang H; Hu T
    Int J Clin Exp Pathol; 2015; 8(3):2590-602. PubMed ID: 26045765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.
    Ho CW; Lin CY; Liaw YW; Chiang HL; Chin YT; Huang RL; Lai HC; Hsu YW; Kuo PJ; Chen CE; Lin HY; Whang-Peng J; Nieh S; Fu E; Liu LF; Hwang J
    Oncotarget; 2016 Sep; 7(38):61930-61944. PubMed ID: 27542280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Sialyl-Tn in Cancer.
    Munkley J
    Int J Mol Sci; 2016 Feb; 17(3):275. PubMed ID: 26927062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44.
    Du T; Jia X; Dong X; Ru X; Li L; Wang Y; Liu J; Feng G; Wen T
    Cancer Manag Res; 2020; 12():511-522. PubMed ID: 32158257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
    Ju T; Wang Y; Aryal RP; Lehoux SD; Ding X; Kudelka MR; Cutler C; Zeng J; Wang J; Sun X; Heimburg-Molinaro J; Smith DF; Cummings RD
    Proteomics Clin Appl; 2013 Oct; 7(9-10):618-31. PubMed ID: 23857728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
    Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
    FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cosmc connection to the Tn antigen in cancer.
    Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
    Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cosmc transfection decreases malignant behavior of Tn
    Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
    Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tn and Sialyl-Tn antigens in canine gastric tissues.
    Flores AR; Lemos I; Rema A; Taulescu M; Seixas F; Reis CA; Gärtner F; Amorim I
    Vet Comp Oncol; 2020 Dec; 18(4):615-625. PubMed ID: 32134186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.
    Fujita R; Hamano H; Kameda Y; Arai R; Shimizu T; Ota M; Sato D; Kobayashi H; Iwasaki N; Takahata M
    Clin Exp Metastasis; 2019 Dec; 36(6):539-549. PubMed ID: 31595388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.